Analisis Risiko Kualifikasi Pemasok dan Pendekatan Mitigasi Risikonya dalam Manajemen Rantai Pasok Industri Farmasi
DOI:
https://doi.org/10.59841/jumkes.v3i2.2536Keywords:
Pharmaceutical Industry, Risk, Risk Mitigation, Supplier Qualification, Supply Chain ManagementAbstract
Pharmaceutical products play a crucial role in supporting medical interventions to prevent, treat, and cure diseases, making their availability and quality key factors in healthcare services. Therefore, the pharmaceutical supply chain must ensure the availability of medicines in adequate quantities and meet quality standards. Supplier qualification is a critical step in supply chain management aimed at ensuring quality, sustainability, and compliance with regulations. This article analyzes the main risks in the supplier qualification process, such as quality risks, compliance risks, and supply disruptions. Risk mitigation strategies, such as regular audits, source diversification, and the implementation of digital technologies, play an important role in enhancing the efficiency, flexibility, and sustainability of the pharmaceutical supply chain, thereby supporting the competitiveness of the industry in consistently meeting market demands and complying with stringent regulatory standards. Through this research, it is hoped that strategic guidelines can be produced to improve the efficiency of pharmaceutical supply chain risk management, resulting in a positive impact on the overall healthcare system.
References
Ali, A., Mahfouz, A., & Arisha, A. (2017). Analysing supply chain resilience: Integrating the constructs in a concept mapping framework via a systematic literature review. Supply Chain Management: An International Journal, 22(1), 16–39.
Annisa, V. (2024). Kajian penerapan good manufacturing practice (GMP) di industri farmasi Indonesia. Majalah Farmasetika, 9(4), 351–366.
APIC. (2009). Supplier qualification & management guideline. European Chemical Industry Council.
BPOM. (2020). Peraturan Badan Pengawas Obat dan Makanan Nomor 6 Tahun 2020. Jakarta: BPOM.
Bravo, A., & Carvalho, J. (2018). Challenging times to pharmaceutical supply chains towards sustainability: A case study application. International Journal of Procurement Management, 8(1), 126.
Brintrup, A., Pak, J., Ratiney, D., Pearce, T., Wichmann, P., & Woodall, P. (2019). Supply chain data analytics for predicting supplier disruptions: A case study in complex asset manufacturing. International Journal of Production Research, 58, 3330.
Centobelli, P., Cerchione, R., & Ertz, M. (2019). Managing supply chain resilience to pursue business and environmental strategies. Business Strategy and the Environment, 29, 1215.
Dermawan, D., Bahtiar, R., & Sofian, F. F. (2018). Implementasi green supply chain management (GSCM) pada industri farmasi di Indonesia: Analisis kelayakan dan studi kasus. Jurnal Ilmiah Farmasi, 15(2), 80–86.
Dermawan, D., Sofian, F. F., & Bachtiar, R. (2017). Tinjauan implementasi penilaian risiko terintegrasi terhadap manajemen rantai pasok pada industri farmasi. Jurnal, 9(1), 76–82.
Dobrzykowski, D. (2019). Understanding the downstream healthcare supply chain: Unpacking regulatory and industry characteristics. Journal of Supply Chain Management, 55(2), 26–46.
Faggioni, F., Ross, M. V., & Sestino, A. (2023). Supply chain resilience in the pharmaceutical industry: A qualitative analysis from scholarly and managerial perspectives. International Journal of Business and Management, 18(1), 129–146.
FDA. (2016). Guidance for industry: Contract manufacturing arrangements for drugs: Quality agreements. U.S. Food and Drug Administration.
Gómez, J. C. O., & Torres España, K. (2020). Operational risk management in the pharmaceutical supply chain using ontologies and fuzzy QFD. Procedia Manufacturing, 51.
Gorani, M. (2024). Optimizing pharmaceutical supply chain: Key challenges and strategic solutions. World Journal of Clinical Medicine Research, 4(1), 35–41.
Harps, L. H. (2000). The haves and the have nots. In Supply chain practices for the new millennium: Inbound Logistics Journal (pp. 75–114).
Harsanti, B. D., & Chaerunisaa, A. Y. (2021). Artikel review: Manajemen risiko mutu, metode serta penerapannya dalam industri farmasi. Farmaka, 19(1), 77–88.
Ho, W., Zheng, T., Yildiz, H., & Talluri, S. (2015). Supply chain risk management: A literature review. International Journal of Production Research, 53(16), 5031–5069.
ICH. (2016). Q7 GMP practice guidance for active pharmaceutical ingredients. U.S. Department of Health and Human Services.
ISPE. (2011). Good practice guide: Quality risk management. International Society for Pharmaceutical Engineering.
Ivanov, D., & Dolgui, A. (2021). A digital supply chain twin for managing the disruption risks and resilience in the era of Industry 4.0. International Journal of Production Research, 59(6), 1836–1853.
Jabbarzadeh, A., Fahimnia, B., & Sabouhi, F. (2018). Resilient and sustainable supply chain design: Sustainability analysis under disruption risks. International Journal of Production Research, 56(17), 5945–5968.
Kadir, M. F., & Sopyan, I. (2020). Kualifikasi pemasok bahan baku yang digunakan pada industri farmasi. Majalah Farmasetika, 5(2), 73–81.
Kamalahmadi, M., & Parast, M. M. (2016). A review of the literature on the principles of enterprise and supply chain resilience: Major findings and directions for future research. International Journal of Production Economics, 171, 116–133.
Kapoor, D., Vyas, R. B., & Dadarwal, D. (2018). An overview on pharmaceutical supply chain: A next step towards good manufacturing practice. Drug Designing & Intellectual International Journal, 1(2).
Klugh, D. B., Lindblad, R. D., Muse, D. G., Ulman, K. L., Walsh, P., & Zawislak, P. S. (2018). Third-party audits: Ensuring that excipients meet cGMP requirements. Pharmaceutical Technology, 4, 10–13.
Kristianto, I., & Tarigan, Z. J. H. (2019). The impact of TQM system on supply chain performance through supply chain integration and employee satisfaction. Petra International Journal of Business Studies, 2(1), 8–17.
Kumar, J., Gururajarao, S. M., Echeverria, E. M. M., Fernandez, C. J., & Sulthan, M. A. (2024). Supply chain resilience and risk management: Strategies for mitigating global supply chain disruptions. Educational Administration: Theory and Practice, 30(6), 2169–2175.
Kusreni, J., Suhartono, & Jati, S. P. (2023). Analisis manajemen risiko pada supply chain persediaan farmasi saat pandemi Covid-19. Cendekia Journal of Pharmacy, 7(1), 29–36.
Kusumo, H., Solechan, A., & Marlina, D. (2022). Mengelola risiko pada manajemen rantai pasokan di industri farmasi. Journal of Management & Business, 5(2), 161–173.
Lima, F., Silva, A., Filho, G., & Dias, E. (2018). Systematic review: Resilience enablers to combat counterfeit medicines. Supply Chain Management: An International Journal, 12(3), 117–135.
Malega, P. (2016). Supplier quality assurance– Step to competitive advantage. International Science Journal about Logistics, 3(2), 17.
Mateo, M., & Anich, N. (2018). Supply chain risk management in the pharmaceutical sector. In ILS 2018—Information Systems, Logistics and Supply Chain. Proceedings.
Mouchantaf, R., Auth, D., Moride, Y., Raine, J., Han, S. Y., & Smith, M. Y. (2021). Risk management for the 21st century: Current status and future needs. Drug Safety, 44(4), 409–419.
Mutahar, A., AlDoaies, B., & Abdulaziz, A. (2017). TQM in healthcare: Transformation, challenges, impact and measurement. International Advanced Research Journal in Science, Engineering and Technology, 4(5).
Nafi’ah, A., & Mahbubah, N. A. (2021). Managing risk on a pharmacy enterprise supply chain using house of risk approach. Journal of Engineering Knowledge, 8(3), 167–182.
Pane, A. N. K., & Herliansyah, M. K. (2022). Manajemen risiko dalam rantai pasok industri farmasi di tingkat pedagang besar farmasi. Prosiding Seminar dan Konferensi Nasional IDEC, 5, 1–9.
Papalexi, M., Bamford, D., & Breen, L. (2020). Key sources of operational inefficiency in the pharmaceutical supply chain. Supply Chain Management: An International Journal, 25(6), 617–635.
Papert, M., Rimpler, P., & Pflaum, A. (2016). Enhancing supply chain visibility in a pharmaceutical supply chain: Solutions based on automatic identification technology. International Journal of Physical Distribution & Logistics Management, 46(9), 859–884.
Quan, N. H. K., & Rajagopal. (2022). Questionnaire designing on the pharmaceutical supply chain model: A pilot study in Ho Chi Minh City, Vietnam. International Journal of Supply Chain, 11(2), 2051–3771.
Queiroz, M. M., Ivanov, D., Dolgui, A., & Wamba, S. F. (2020). Impacts of epidemic outbreaks on supply chains: Mapping a research agenda amid the COVID-19 pandemic through a structured literature review. Annals of Operations Research, 319, 1159–1196.
Ridho, M., Karel, M., Tedja, & Suryadarma, M. (2018). Analisis pendekatan mitigasi risiko pada aktivitas rantai pasok dengan metode pendekatan supply chain operation reference serta metode house of risk di PT. Barentz. Industrial Engineering Online Journal, 3(1), 149–162.
Sarkar, S. (2022). Digital traceability of pharmaceutical drugs in supply chain. International Journal, 10(2).
Sinen, Y., Lolo, W. A., & Supriati, H. S. (2017). Evaluasi penyimpanan dan pendistribusian obat di PT. Unggul Jaya Cipta Usaha Manado. Pharmacon, 6(3), 137–146.
Singh, R. K., Kumar, R., & Kumar, P. (2016). Strategic issues in pharmaceutical supply chains: A review. International Journal of Pharmaceutical and Healthcare Marketing, 10(3).
Swierczek, A. (2016). The "snowball effect" in the transmission of disruptions in supply chains: The role of intensity and span of integration. The International Journal of Logistics Management, 27(3), 1002–1038.
Therapeutic Goods Administration. (2019). Supplier assessment, approval and qualification for listed and complementary medicines: Technical guidance on the interpretation of the PIC/S Guide to GMP (2nd ed.). Therapeutic Goods Administration.
Tucker, E. L., & Daskin, M. S. (2022). Pharmaceutical supply chain reliability and effects on drug shortages. Computers & Industrial Engineering, 169, 108258.
Vamsi, B., Hemanth Kumar, S., Patel, P. R., & Gowrav, M. P. (2020). Vendor qualification and evaluation in pharmaceutical industry. International Journal of Research in Pharmaceutical Sciences, 11(2), 1987–1994.
Wang, M., & Jie, F. (2020). Managing supply chain uncertainty and risk in the pharmaceutical industry. Health Services Management Research, 33(3), 1–9.
WHO. (2020). Good manufacturing practices for pharmaceuticals. World Health Organization.
Yaroson, E. V., Breen, L., Hou, J., & Sowter, J. (2020). Advancing the understanding of pharmaceutical supply chain resilience using complex adaptive system (CAS) theory. Supply Chain Management: An International Journal, 26(3).
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2025 Jurnal Mahasiswa Ilmu Kesehatan
This work is licensed under a Creative Commons Attribution-ShareAlike 4.0 International License.
